In Vivo Transplantation of Enteric Neural Crest Cells into Mouse Gut; Engraftment, Functional Integration and Long-Term Safety by Cooper, JE et al.
RESEARCH ARTICLE
In Vivo Transplantation of Enteric Neural
Crest Cells into Mouse Gut; Engraftment,
Functional Integration and Long-Term Safety
Julie E. Cooper1, Conor J. McCann1, Dipa Natarajan1, Shanas Choudhury1,
Werend Boesmans2, Jean-Marie Delalande1,3, Pieter Vanden Berghe2, Alan J. Burns1,4*,
Nikhil Thapar1,5*
1 Stem Cells and Regenerative Medicine, UCL Institute of Child Health, 30 Guilford Street, London, United
Kingdom, 2 Laboratory for Enteric NeuroScience, Translational Research Center for GastroIntestinal
Disorders, Department of Clinical and Experimental Medicine, University of Leuven, Leuven, Belgium,
3 Centre for Digestive Diseases, Blizard Building, Barts & The London School of Medicine & Dentistry,
Queen Mary, University of London, London, United Kingdom, 4 Department of Clinical Genetics, Erasmus
MC University Medical Centre, Rotterdam, The Netherlands, 5 Department of Gastroenterology, Great
Ormond Street Hospital NHS Foundation Trust, Great Ormond Street, London, United Kingdom
* n.thapar@ucl.ac.uk (NT); alan.burns@ucl.ac.uk (AJB)
Abstract
Objectives
Enteric neuropathies are severe gastrointestinal disorders with unsatisfactory outcomes.
We aimed to investigate the potential of enteric neural stem cell therapy approaches for
such disorders by transplanting mouse enteric neural crest cells (ENCCs) into ganglionic
and aganglionic mouse gut in vivo and analysing functional integration and long-term
safety.
Design
Neurospheres generated from yellow fluorescent protein (YFP) expressing ENCCs
selected from postnatalWnt1-cre;R26R-YFP/YFPmurine gut were transplanted into gangli-
onic hindgut of wild-type littermates or aganglionic hindgut of Ednrbtm1Ywamice (lacking
functional endothelin receptor type-B). Intestines were then assessed for ENCC integration
and differentiation using immunohistochemistry, cell function using calcium imaging, and
long-term safety using PCR to detect off-target YFP expression.
Results
YFP+ ENCCs engrafted, proliferated and differentiated into enteric neurons and glia within
recipient ganglionic gut. Transplanted cells and their projections spread along the endoge-
nous myenteric plexus to form branching networks. Electrical point stimulation of endoge-
nous nerve fibres resulted in calcium transients (F/F0 = 1.16±0.01;43 cells, n = 6) in YFP+
transplanted ENCCs (abolished with TTX). Long-term follow-up (24 months) showed trans-
planted ENCCs did not give rise to tumours or spread to other organs (PCR negative in
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extraintestinal sites). In aganglionic gut ENCCs similarly spread and differentiated to form
neuronal and glial networks with projections closely associated with endogenous neural
networks of the transition zone.
Conclusions
Transplanted ENCCs successfully engrafted into recipient ganglionic and aganglionic gut
showing appropriate spread, localisation and, importantly, functional integration without any
long-term safety issues. This study provides key support for the development and use of
enteric neural stem cell therapies.
Introduction
Enteric neuropathies represent some of the most severe clinical gastrointestinal (GI) disorders
and are characterised by failure of normal propulsive contractile activity leading to functional
obstruction to the flow of luminal contents.[1–3] Archetypal disorders include the congenital
disorder Hirschsprung disease and acquired oesophageal achalasia, which result from an abso-
lute absence or loss of intrinsic enteric neurons in the distal and proximal parts of the GI tract
respectively. More subtle neuronal defects underlie other disorders such as intestinal pseudo-
obstruction and slow transit constipation, which show evidence of neuropathy on histology or
on contractile profiles from intestinal physiological studies.[4–7]
Enteric neuropathies are generally devastating conditions, which left untreated are life
threatening. Current available treatments are largely limited to surgery to decompress the
intestine or resect its most abnormal segments and the provision of specialised nutrition, often
parenteral, to preserve growth and development. Outcomes of such interventions are often
unsatisfactory and associated with significant complications[8, 9] highlighting the need for
alternative approaches.
Tremendous advances in regenerative medicine have brought the prospect of neural regen-
eration to replace deficient or defective enteric neurons as a potential therapeutic strategy for
enteric neuropathies to the forefront.[8, 10–12] Several cell types have been identified as poten-
tial sources of donor cells for a cell replacement therapy, such as skin-derived precursors and
central nervous system progenitors [13–16]. Arguably the most promising progress towards
this ultimate goal has been made using enteric neural crest cells (ENCCs) which comprise
enteric neural stem cells, neurons and glia and are derived from the original population of
migratory neural crest cells (NCC) that, during embryogenesis, colonise the gut to form the
enteric nervous system (ENS) [17–22].
The isolation of enteric neural stem cells was first described over a decade ago from murine
gut, including models of Hirschsprung disease.[23] Since then there has been steady progress
emanating from the isolation of such cells from human intestine including from the gut
mucosa of patients obtained by conventional endoscopy[24]. We and others have shown that
ENCCs contained within discrete cellular aggregates or neurospheres (including enteric neural
stem cells, neurons and glia) formed in culture can colonise recipient bowel in vitro.[23–32].
Most recently, in vivo studies have confirmed that ENCCs, predominantly from embryonic
mouse gut, are capable of migration, proliferation and differentiation and they retain some
functionality after transplantation into postnatal mouse gut.[16, 33–36] Although these initial
studies have addressed aspects of feasibility of ENS stem cell transplants, a number of chal-
lenges remain, including questions concerning long-term safety and the ability of transplanted
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cells to form neural networks, which connect to the endogenous enteric neural network. The
ability to form an integrated and functional ENS after transplantation, in vivo, will be critical in
the treatment of both aganglionic and euganglionic enteric neuropathies.
In this paper we confirm that postnatal mouse-derived ENCCs can colonise ganglionic
mouse gut in vivo and form neural networks, which functionally integrate with endogenous
ENS. We show that ENCCs similarly colonise aganglionic bowel. The transplanted cells do not
appear to pose any long-term safety risk within the recipient animals.
Materials and Methods
Animals
Animals used for this study were maintained and the experiments performed were in accor-
dance with the local approvals and the UK Animals (Scientific Procedures) Act 1986 under
licence from the Home Office (PPL70/7500).Wnt1-cre;R26R-YFP/YFPmice[37–39] in
which NCC express yellow fluorescent protein (YFP) were used to obtain YFP+ enteric
NCC (ENCCs). R26R-YFP/YFP littermates (in which YFP is not expressed in the absence of
cre) were used as ganglionic recipient bowel into which YFP+ ENCCs were transplanted.
Ednrbtm1Ywa mice lacking endothelin receptor type B (a model for Hirschsprung Disease)
(obtained from Jackson Laboratory (JAX#003295)) were used as aganglionic recipient bowel
for YFP+ ENCCs.
Isolation, cell sorting and culture of ENCCs
YFP+ ENCCs were obtained from early postnatal (P2-P4)Wnt1-cre;R26R-YFP/YFPmice.
Muscle strips of bowel (containing muscle layers and myenteric and submucosal plexuses)
were dissociated enzymatically (Collagenase, Sigma, 1mg/ml) for 30 minutes at 37°C. Dissoci-
ated cells were washed with neurosphere medium (NSM) (DMEM F12 supplemented with B27
(InvitrogenLife Technologies, UK), N2 (Life Technologies, UK), 20ng/ml EGF (Peprotech,
UK), 20ng/ml FGF (Peprotech, UK), and Primocin antibiotic (Invivo Gen, UK)) and filtered
through a 100μm and 40μmmesh.
ENCCs were isolated from the total cell population using fluorescence activated cell sorting
(FACS) for YFP. Dissociated cells were resuspended in NSM with 2% foetal calf serum before
undergoing FACS using a MoFloXDP cell sorter (Beckman Coulter).
ENCC were washed with NSM before plating on fibronectin-coated wells of 6-well dishes in
NSM. They were maintained in culture and generated neurospheres from around 1 week. Pri-
mary neurospheres generated in cultures maintained for a maximum of 30 days were used for
the transplants.
Transplantation of ENCCs into gut in vivo
YFP expressing ENCCs derived fromWnt1-cre;R26R-YFP/YFPmice were transplanted into
the ganglionic distal colon of ‘wild-type’ R26R-YFP/YFP littermates (which did not express
YFP in the absence of cre) via laparotomy at weaning (postnatal day 21) (n = 66). The same
YFP expressing ENCCs were transplanted into Ednrbtm1Ywa mutants (identified by their pie-
bald markings) as early as practically possible at postnatal day 9–13 (n = 5).
Laparotomy was conducted under isoflurane anaesthesia, using 0.05% carprieve (Norbrook)
and 0.25% marcaine polyamp (AstraZenica) analgesic agents. An incision was made in the
lower abdomen through the peritoneum to reveal the bowel. The most distal portion of colon
accessible from within the peritoneal cavity (around 0.5cm from the rectum), was exposed.
ENCCs, as neurospheres (3 per animal), were selected using a fine glass capillary attached to a
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mouth pipette and inserted into a small pocket in the serosa of the bowel using the bevel of a
syringe needle. The exteriorised bowel was returned to the abdomen and the laparotomy inci-
sion was closed using a combination of absorbable sutures (Ethicon) and wound clips (World
Precision Instruments), which were removed 7 days post-surgery.
Bromodeoxyuridine (BrdU) (Sigma, UK; 10mM (10μl/g weight of 10 mg/ml BrdU) in PBS)
was injected intraperitoneally at the time of surgery with additional application 24 hours post
surgery.
Transplanted R26R-YFP/YFPmice were checked periodically following surgery and of those
transplanted 4 (of 66) were in obvious discomfort in the 12 hours following surgery and were
euthanised according to protocol. The cause was determined to be perforation of the bowel.
The rest were typically maintained for around 4 weeks post-transplantation before sacrifice
and removal of bowel for analysis, although some animals were maintained up to 24 months to
obtain long-term safety data. Three of the 5 transplanted Ednrbtm1Ywa mutants developed
abdominal swelling and loss of condition without obvious intestinal perforation 2–4 days after
transplant and were euthanized. The other 2 animals were euthanized at day 5 post-transplant.
PCR
In order to ascertain whetherWnt1-cre;R26R-YFP/YFP-derived transplanted cells migrated to
locations other than the gut following transplantation into R26R-YFP/YFP recipients, PCR was
performed to identify the cre transgene. Brain, lungs, heart, liver, spleen, kidneys, adrenal
glands and gut mesentery were collected on sacrifice and frozen.Wnt1-cre;R26R-YFP/YFP pos-
itive control tissue was obtained fromWnt1-cre;R26RYFP/YFP gut tissue, transplanted gut, YFP+
neurospheres and aWnt1-cre;R26RYFP/YFP ear biopsy. DNA was extracted using DNAReleasy
(Anachem) diluted 1μl in 4μl water and heated to 75°C for 5min followed by 96°C for 2 min.
PCR was performed using cre primers (5’-ACCCTGATCCTGGCAATTTCGGC and 5’-
GATGCAACGAGTGATGAGGTTCGC) and a cycle with a 60°C annealing temperature.
Immunohistochemistry
Cells and transplanted bowel were fixed and analysed using immunohistochemistry as
described previously[24, 40]. The primary and secondary antibodies used in the study are listed
in Table 1 and Table 2.
Briefly, for wholemount immunolabelling, gastrointestinal tracts were fixed in 4% PFA (1h),
washed (2x10min, PBS) and then blocked (1h –overnight, wholemount blocking solution (WBS)
(PBS, 2% Triton X-100, 10% sheep serum). Primary antibodies were applied for 48h at 4°C before
washing (2x1h, PBS with 1% Triton X-100) and addition of secondary antibodies (24h, 4°C). Sec-
ondary antibodies were washed and samples mounted on glass coverslips for imaging.
For labelling with BrdU antibody, samples were first labelled with other primary antibodies
as described above. Samples were post fixed (4% PFA,10 min, RT) and washed 3x in PBS. This
was followed by treatment with 2M HCl for 15minutes at RT. After washing (3x15min), Rat
anti-BrdU (Oxford Biotech, UK, 1:20) was applied overnight at 4°C, followed by goat anti-rat
568 (1:500) secondary antibody. Post antibody washings and mounting were carried out as
described above.
Images were acquired on a Zeiss LSM 710 confocal microscope (Zeiss, Cambridge, UK) and
were processed using ImageJ and Adobe Photoshop software[41, 42].
Calcium imaging of transplanted mouse ENCCs
Colonic segments were removed from transplanted mice as described and immediately
immersed in previously oxygenated (95% oxygen/5% carbon dioxide) Krebs solution (in mM:
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120.9 NaCl, 5.9 KCl, 1.2 MgCl2, 2.5 CaCl2, 11.5 glucose, 14.4 NaHCO3 and 1.2 NaH2PO4).
After removing the mucosa, gut preparations were pinned tightly, serosal side up, in a Sylgard-
lined chamber. Transplanted YFP+ cells were identified and imaged at this stage.
Tissues were then loaded with the fluorescent Ca2+ indicator Fluo-4AM (Molecular Probes,
Invitrogen; 5mM) and Cremophor EL (Fluka Chemika, Buchs, Switzerland; 0.01%) in Krebs
solution at room temperature for 20 minutes with continuous oxygenation.
After loading, tissues were washed (2x10 min, Krebs) prior to imaging. Live fluorescence
imaging was performed on a Zeiss Examiner microscope equipped with a 20x (NA 1) water
dipping lens, Poly V monochromator (TILL Photonics, Gräfelfing, Germany) and cooled CCD
camera (Imago QE; TILL Photonics, Gräfelfing, Germany). The experimental chamber volume
was maintained at 3ml via a gravity-fed perfusion system ensuring continuous perfusion
(1ml/min) with 95% oxygen/5% carbon dioxide-gassed Krebs solution (at RT), excess solution
was removed via a peristaltic suction pump. Fluo-4 was excited at 475nm, and its fluorescence
emission was collected at 525/50 nm. Images (640X512 pixels2) were acquired at 2 Hz.
Electrical train stimulation (2 s, 20 Hz of 300 μs electrical pulses; Grass Instruments,
Quincy, Massachusetts, USA) was applied via a platinum electrode (diameter 25 μm), inserted
at a distance of 200μm from the most peripheral YFP+ cell or fibre in the observed transplanted
region of interest. Care was taken during this insertion to ensure contact was restricted to
endogenous (non YFP+) fibres. To confirm the neuronal origin of the signal in YFP+ trans-
planted cells, experiments were conducted in the presence of tetrodotoxin (1 μM, Sigma, Bor-
nem, Belgium). Local application of high K+ was also used as a means of determining basic
functionality of transplanted cells within host tissues.
Table 1. Primary antibodies for immunohistochemistry studies.
PRIMARY ANTIBODY CONCENTRATION COMPANY
Mouse anti-TuJ1 1:500 Covance
Mouse anti-GFAP 1:500 Dako
Rabbit anti-GFP 1:500 Invitrogen
Mouse anti-GFP 1:500 Invitrogen
Chicken anti-GFP 1:500 Abcam
Goat anti-Sox10 1:300 Santa Cruz
Rabbit anti-S100 1:400 Dako
Rabbit anti-nNOS 1:400 Invitrogen
Rabbit anti-VIP 1:400 AbD Serotec
Goat anti-ChAT 1:300 Millipore
Rat anti-BrdU 1:20 Oxford Biotech
Mouse anti-Synaptophysin 1:250 AbD Serotec
doi:10.1371/journal.pone.0147989.t001
Table 2. Secondary antibodies for immunohistochemistry studies.
SECONDARY ANTIBODY ALEXA FLUOR CONCENTRATION COMPANY
Goat anti-rabbit 488 1:500 Invitrogen
Goat anti-mouse 488 1:500 Invitrogen
Anti-chicken 488 1:500 Abcam
Anti-mouse 568 1:500 Invitrogen
Anti-rabbit 568 1:500 Invitrogen
Anti-mouse 647 1:500 Invitrogen
Anti-rabbit 647 1:500 Invitrogen
doi:10.1371/journal.pone.0147989.t002
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Images were collected using TILLVision software (TILL Photonics) and post acquisition
analysis performed in IGOR PRO (Wavemetrics, Lake Oswego, Oregon, USA). Movement arti-
facts were removed by registering the image stack to the first image. Regions of interest (ROI)
were drawn over each cell, fluorescence intensity was normalised to basal fluorescence for each
ROI(F/F0), and peaks analysed [43–45].
Results
YFP+ ENCCs form neurospheres containing neurons, glia and
presumptive enteric neural stem cells
Intestinal muscle strips were taken fromWnt1-cre;R26R-YFP/YFPmice aged P2-4 in which
NCC and their derivatives express YFP. Following gut dissociation, YFP+ ENCCs were selected
by FACS where these cells accounted for 16.5±1.9% (n = 6) of the total gut cell population (Fig
1A). Selected YFP+ mouse ENCCs formed characteristic neurospheres of approximately 20μm
in diameter within 2 weeks in culture, which increased in size to approximately 120μmwithin
a month (Fig 1B). The neurospheres comprised cells expressing ENS markers such as the pan-
neuronal marker TuJ1 (31.7%±3.2% of cells within the neurosphere (n = 3)) and the glial
marker GFAP (27.7%±5.9% (n = 3)), which maintained their YFP expression throughout cul-
ture (Fig 1C). They also contained cells that were immunopositive for Sox10 but negative for
GFAP (Fig 1D), the expression profile of presumptive enteric neural stem cells (Sox10+ cells
accounted for 67.7%±8.7% of cells within the neurosphere (n = 3), thus Sox10+;GFAP- enteric
neural stem cells accounting for around 40%).
Transplanted ENCCs show appropriate colonisation, localisation and
formation of ENS-like networks in ganglionic host gut
YFP+ neurospheres were transplanted into postnatal wild-type mouse distal hindgut. YFP+
transplanted ENCCs were subsequently identified within the gut wall of 56/62 animals exam-
ined (90.3%), up to 24 months post-transplantation. Within the gut, YFP+ ENCCs spread
orally and anally from the site of transplantation and formed extensive branching networks co-
located with the endogenous ENS (Fig 2A including inset and S1 Fig panel A). By 15 weeks
post-transplantation YFP+ networks, on average, covered an area of 4.3±3.1mm2 and cell bod-
ies were observed at a distance of 1.4±0.4mm from the site of transplantation (n = 10) (S1 Fig
panel B and C). These parameters, as well as the proximal-distal spread of transplanted cells,
showed positive correlation to the number of days post-transplantation (S1 Fig panel B
(r = 0.68, n = 32, p<0.01); 1C (r = 0.54, n = 28, p<0.01); and 1D (r = 0.51, n = 28 p<0.01)
respectively). There was no significant difference between the mean oral (0.9±0.38mm) and
aboral (0.9±0.4mm) spread (t = 0.45, n = 6, p<0.5).
Cell bodies (Fig 2B) of, and projections (arrowhead, Fig 2A) from, transplanted YFP+TuJ1+
neuronal cells were located within the endogenous myenteric plexus and projected within it for
several millimetres. Punctate labelling around transplanted cells with the synaptic vesicle pro-
tein synaptophysin (arrowheads, Fig 2C) suggested synapse formation within the host gut.
Transplanted YFP+ ENCCs show functional integration within host gut
In order to test the functional integration of transplanted YFP+ ENCCs within the host gut mus-
culature, we examined [Ca2+]i upon electrical stimulation of the endogenous enteric neural net-
work (Fig 3A) or used application of high K+ as a means of neuronal activation. Electrical point
stimulation of endogenous enteric nerve fibres resulted in calcium transients (F/F0 = 1.16±0.01;
43 cells, n = 6) in both the cell bodies and fibres of YFP+ transplanted ENCCs (Fig 3B–3D and
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Fig 1. Isolation and culture of YFP+ enteric neural crest cells (ENCC) from postnatal Wnt1-cre;R26RYFP/YFPmouse gut. A. Flow cytometry profile
showing the YFP+ cell population (green) separate from the enteric cell population (pink).B. Selected YFP+ cells form YFP+ neurospheres after 7 days in
culture.C. Immunohistochemical analysis confirms that all cells within the neurospheres express YFP (green;Civ, Div). Neurospheres contain cells
immunopositive for the neuronal marker TuJ1 (red; C, Ci) and the glial marker GFAP (cyan; C, Cii). DAPI labels nuclei in blue (Ciii). D. Neurospheres
In Vivo Transplantation of Enteric Neural Crest Cells
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S1Movie). These calcium transients were abolished in the presence of 1μMTTX, confirming
their neuronal identity (Fig 3D and 3E; 43 cells, n = 6) (S1Movie). Local application of high K+
also resulted in similar widespread calcium transients throughout YFP+ transplanted cell net-
works and contributed to large contractions of the musculature (data not shown).
Transplanted YFP+ ENCCs generate a range of ENS cell types in vivo
The ENS cell-types of transplanted YFP+ ENCCs were analysed by immunofluorescence
4-weeks after transplantation. 53±14% of transplanted cells expressed the neuronal marker
TuJ1 (n = 13) (Fig 4A and S2 Fig panel A and S3 Fig panel A). nNOS expressing cells accounted
for the majority of neurons (50±5% of transplanted cells; Fig 4B and S2 Fig panel B and S3 Fig
panel A). Transplanted cells expressed other neuronal markers, such as ChAT, Calbindin and
VIP (S2 Fig panels C, D and E respectively) but these cell types were less numerous (data not
shown). Transplanted cells also expressed the glial cell markers S100 and GFAP (Fig 4C and S2
Fig panel F and G). S100+ cells comprised 64±22% of transplanted cells (S3 Fig panel A; n = 3).
YFP+ ENCCs proliferate post-transplant giving rise to enteric neurons
and glia
The proliferative capability of transplanted YFP+ cells was assessed by BrdU incorporation.
BrdU pulses were administered at transplantation and 24h later. BrdU incorporation was iden-
tified within YFP+ cells and quantified in different cell types (S3 Fig panel B). 26±19% of
(outlined by dotted lines) also contain cells (asterisk and arrowheads) that express Sox10 (red;D, Di andDiii, arrowheads) but are negative for GFAP (cyan;
D, Dii) i.e. presumptive ENSSCs. Inset inD shows a cross section through a Sox10+/GFAP- cell (red only; asterisk; presumptive ENSSC) adjacent to a
Sox10+/GFAP+ cell (red and cyan; presumptive glial cell). Scale bar in B-D = 20μm.
doi:10.1371/journal.pone.0147989.g001
Fig 2. ENCCs from transplanted murine neurospheres show appropriate colonisation, localisation and formation of ENS-like networks in recipient
wild-type gut. A.Wholemount gut preparation showing YFP+ transplanted cells (green) projecting along endogenous TuJ1+ (red) ENS nerve fibres. Arrow
indicates cell bodies at the presumptive site of transplantation and arrowhead indicates distal extent of projections of transplanted cells. YFP+ transplanted
cells also expressing the neuronal marker TuJ1 are seen as yellow. Inset shows a high power image taken from boxed region in S1 Fig panel A revealing
interconnections and network formation between YFP+ cell bodies.B. Confocal 3D reconstruction showing YFP+ transplanted cells (green) located at the
site of transplantation on the serosal surface (S) and within the myenteric plexus (MYP; arrowheads) between the inner circular (CM) and outer longitudinal
(LM) muscle layers.C. YFP+ transplanted cells (green) co-locate with the synaptic marker synaptophysin (red; arrowheads). Scale bar in A = 100μm;C =
25μm. Inset in C shows individual channels.
doi:10.1371/journal.pone.0147989.g002
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TuJ1+ cells (Fig 4A and S3 Fig panels B and C; n = 13), 36±19% of nNOS+ cells (Fig 4B and S3
Fig panel B, n = 3) and 32±17% of S100+ cells (Fig 4C and S3 Fig panel B; n = 3) showed BrdU
incorporation. This suggests that varying proportions of transplanted cells expressing neuronal
and glia markers are derived from cells that proliferate during the 48hrs following
transplantation.
Transplanted YFP+ ENCCs do not show uncontrolled proliferation, form
tumours or spread to other organs
Long-term studies of mice that were the recipients of YFP+ ENCC transplants were con-
ducted to assess safety of these transplants. Although initial BrdU exposure (48 hours after
transplantation) resulted in BrdU incorporation in transplanted cells, exposure 48hrs prior
to culling at 4 weeks post-transplantation did not show BrdU incorporation (data not
shown) suggesting there was no uncontrolled proliferation of transplanted cells. Macro-
scopic and PCR examination of transplanted animals and tissues aged 19–25 months
(including brain, lungs, heart, liver, spleen, kidneys, adrenal glands and gut mesentery)
failed to identify any YFP fluorescence or cre transgene within organs other than the gut
and positive controls (Fig 4D).
Fig 3. Transplanted YFP+ cells show functional integration within host gut. A. Schematic of experimental protocol demonstrating electrical point
stimulation of host enteric nerve fiber at a site distant from YFP+ transplanted cells.B,C.Representative images of YFP+ cells before (B) and after (C)
Fluo4-AM loading. Arrows indicate transplanted neurons (TP cell) from which Ca2+ responses are plotted in (D). D. Representative traces showing Ca2+
responses recorded as F/F0 from TP cell in control conditions (solid lines) and after addition of TTX (dotted lines). E. Summary data demonstrating abolition
of Ca2+ responses in the presence of TTX (43 cells, n = 6). Also see S1 Movie.
doi:10.1371/journal.pone.0147989.g003
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YFP+ ENCCs transplanted into aganglionic Ednrbtm1Ywa gut form
branching neuronal networks
Ednrbtm1Ywa mice are characterised by a variable length of aganglionosis in the distal colon and
mutants within our colony survive for around two weeks. Tuj1 immunohistochemistry showed
the proximal colon appeared normally ganglionated (Fig 5A and 5Ai) progressing distally to
the hypoganglionated region of transition zone (Fig 5A and 5Aii) and to the distal-most bowel,
which, although showing innervation by extrinsic fibres, lacks an intrinsic ENS (Fig 5A and
5Aiii).
YFP+ neurospheres were transplanted into the most distal portion of hindgut accessible
from the peritoneal cavity of Ednrbtm1Ywa mice (n = 5). Transplanted cells survived and could
be identified by their YFP fluorescence in 4 out of 5 guts after 3–5 days (Fig 5B). Transplanted
Fig 4. Transplanted YFP+mouse ENCCs proliferate and generate enteric neurons and glia but do not spread beyond transplanted gut. A-C. Z-
projections in which transplanted YFP+ cells co-express ENSmarkers (yellow; arrowheads) including the pan-neuronal marker TuJ1 (A), the inhibitory
neuronal marker nNOS (B), and the glial marker S100 (C). Transplanted cells co-expressing ENSmarkers also demonstrate BrdU incorporation (cyan;
arrowheads; A-C and insets). DAPI labels nuclei in blue (A-C and insets). Insets show individual channels. D.Wnt1-cre;R26RYFP/YFP expressing transplanted
cells (YFP+) were identified within R26RYFP/YFP recipient mice by the presence of the cre transgene on PCR. Representative cre-PCR to identify cre
expressing cells within the major organs from a transplanted mouse. Brain (B), lungs (Lu), heart (H), liver (Li), spleen (S), kidneys (K), adrenal glands (A) and
gut mesentery (M) were all negative for cre. Control tissues:Wnt1-cre;R26RYFP/YFP gut tissue (C1), transplanted gut (C2), YFP+ neurospheres (C3) and
Wnt1-cre;R26RYFP/YFP ear biopsy (C4) are cre+. Scale bar in A-C = 20μm.
doi:10.1371/journal.pone.0147989.g004
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cells included both Tuj1+ neurons (Fig 5Bii) and S100+ glia (data not shown) and had spread
out to form interconnected neural networks (Fig 5Bi). Furthermore projections from trans-
planted neuronal cells associated closely with the endogenous neurons of the transition zone
(Fig 5Bii and inset in 5Bii).
Discussion
Our studies confirm the feasibility of the in vivo transplantation of post-natally sourced
ENCCs into both ganglionic and aganglionic post-natal intestine. Not only are transplanted
cells able to engraft successfully into significant segments of intestine they are able to show crit-
ical functional integration with the endogenous neural networks. Importantly, our work sug-
gests that ENCC transplantation is safe in the long-term.
Fig 5. YFP+ ENCC colonise aganglionic Ednrbtm1Ywa gut in vivo. A. Neurons in an Ednrbtm1Ywa colon immunolabelled with TuJ1 progressing from
proximal ganglionated gut (Ai), through the partially ganglionated transition zone (Aii) to the distal aganglionic gut (Aiii). B. Ednrbtm1Ywa gut 3 days after
transplantation with YFP+ ENCCs (green) which could be identified in distal colon. Boxed area is area enlarged in Bi and asterisk denoted presumptive site of
transplantation in this region.Bi. Interconnections are visible between transplanted cells that have spread from the site of transplantation. Bii. Z-projections in
which endogenous neurons express the neuronal marker Tuj1 (red; arrow) and YFP+ transplanted cells (green) also coexpress Tuj1 (yellow; arrowhead).
Projections from YFP+;Tuj1+ transplanted cells closely associate with projections from endogenous Tuj1+ neurons present in the transition zone (insets in
Bii; arrowheads and arrows respectively). Scale bar in Bi = 100μm; Bii = 50μm. DAPi is shown in blue.
doi:10.1371/journal.pone.0147989.g005
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Only one other study to date has robustly tested engraftment and functional integrity of
ENCCs following in vivo transplantation [32]. Our study, however, extended this work signifi-
cantly across a number of domains from assessment of engraftment, post-transplant cell
behaviour and functional integration with endogenous neurons, through to long-term studies
of viability and safety. We were also able to assess in vivo transplantation into aganglionic
intestine.
Our exclusive use of postnatal intestine in the in vivo setting as both donor and recipient of
ENCCs served to best recapitulate the clinical setting of autologous transplantation. We have
previously shown that ENCCs can be harvested from human post-natal gut, even utilising min-
imally invasive techniques such as endoscopy. Such cells successfully colonised recipient agan-
glionic gut either embryonic gut maintained on chorioallantoic membrane or human gut
maintained in vitro [24]. Although human ENCCs remain to be tested in the in vivo setting our
murine studies confirm that the therapeutic strategy of autologous transplantation of ENCCs
into aganglionic and euganglionic intestine is a viable option.
Previous studies have suggested that recipient intestine with established endogenous enteric
neurons is poorly receptive to transplanted cells [10]. Our studies and those of others [16, 33,
35, 46] confirm this not to be the case opening up the considerable potential for ENCC therapy
for a range of enteric neuropathies not characterised by aganglionosis such as slow transit con-
stipation, intestinal pseudo-obstruction or those occurring following injury.
In our studies transplanted ENCCs showed significant proliferation in recipient intestine
following transplantation. BrdU assays confirmed that although highly proliferative following
delivery (giving rise to both neurons and glia in approximately equal proportions), trans-
planted cells did not continue to proliferate and seem to achieve a steady state within a few
weeks. This mimics the behaviour of the endogenous ENS after insult or injury [47] implying
that transplanted cells may be responding to endogenous signalling mechanisms tasked with
maintaining the structural and functional integrity of the ENS, perhaps at the site of injury sec-
ondary to implantation of the neurospheres. Nonetheless, this capacity to expand until pre-
sumably a status quo is achieved holds huge promise given it suggests that sufficient
‘therapeutic’ cells may be generated following transplant to colonise and integrate within the
recipient ENS.
Of course therapeutic success is reliant on appropriate differentiation and functional inte-
gration. In our studies, and as recently reported [32], we utilised YFP+ ENCCs derived from
postnatalWnt1-cre;R26R-YFP/YFP mice to generate YFP+ neurospheres, comprised of mature
neurons and glia as well as enteric neural stem cells but devoid of non-ENS cells (e.g. smooth
muscle and fibroblast-like cells). Upon transplantation, the YFP+ ENCCs were capable of gen-
erating both neurons and glia including a range of neuronal subtypes. Importantly nNOS+
cells were the predominant neuronal subtype evident in transplanted ENCCs. This may be crit-
ical for therapy of enteric neuropathies, many of which are characterised by loss of ENS or
more specifically of inhibitory nNOS neurons with tonic contraction and a failure of adequate
relaxation of the affected intestine[48, 49]. Our further studies will aim to determine whether
the nNOS component of transplanted cells is capable of restoring the inhibitory response in
models of nNOS deficiency
Transplanted ENCCs localised to the myenteric plexus and with their projections followed
established networks for considerable distances, which, accompanied by expression of the syn-
aptic marker synaptophysin, suggested integration with the host neuromusculature. In work by
Hotta et al the authors made intracellular recordings of individual transplanted ENCCs con-
firming them to be functionally active neurons and suggesting their functional integration
within recipient gut [35]. Using the different approach of intracellular calcium imaging we
were able to further show that stimulation of endogenous enteric nerve fibres resulted in
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widespread calcium transients throughout multiple cells within YFP+ transplanted neural net-
works. Such firing of multiple transplanted cells suggests integration of circuitry, which would
be required to impart functional improvements in models of neuropathy. This technique has
been used widely to demonstrate ENS functionality [44, 45]. These studies do suggest func-
tional integration of the transplanted networks with the endogenous neuromusculature but do
not confirm that this translates to changes in colonic motility as measured by contractile func-
tion or indeed transit of luminal contents. The use of wild-type ganglionic intestine precludes
this assessment given it is unlikely that one is able to see a supra-physiological change in motil-
ity. This will need to be done in the context of models of enteric neuropathy or aganglionosis.
To date studies demonstrating the colonisation of aganglionic gut by transplanted ENCCs
have been almost completely limited to in vitro experiments [24, 28] given the very poor sur-
vival of the mouse models of Hirschsprung disease. We have been able to progress these studies
into in vivo transplantation with data that supports the ability of ENCCs to rebuild neural net-
works. Although, the survival of recipient EDNRB null animals was limited we were able to
deliver the cells in vivo and show that they were able to engraft successfully. Accepting a short
duration for assessment transplanted ENCCs survived, spread out and formed close associa-
tions with endogenous neurons, providing promise that in a therapeutic setting transplanted
ENCCs may be able to make the connections with the endogenous ENS required to make func-
tional circuitry. Although, in keeping with the experience of others, our experiments continue
to be hampered by the poor survival of mouse models of Hirschsprung Disease (including
Ednrb and monoisoformic Ret51), novel strategies may facilitate future studies in such animals.
Stamp et al recently report a surgical model in a rat model of Hirschsprung disease whereby
formation of an intestinal stoma enabled good post-natal survival and well-being theoretically
facilitating assessment of transplants[50]. Alternatives include the use of less affected models of
enteric neuropathy, such as the nNOS null mutant, which is compatible with survival, but has
detectable neurological deficits [51], or other models of aganglionosis such as chemical ablation
of the ENS using treatments such as benzalkonium chloride (BAC) [47, 52].
A strength of our studies is the robust assessment of long-term safety up to 24 months post
transplantation. We could consistently visualise transplanted YFP+ cells within hindguts of
recipient mice in these end stage experiments, however we never observed YFP-derived
tumours in any organ. Additionally PCR analysis demonstrated that transplanted cells were
restricted to the distal colon with no evidence of spread or seeding to sites away from the target
organ. This containment of transplanted cells taken together with their restricted proliferative
capacity to the period immediately following transplantation provides critical safety data for
the application of any future cellular therapy. Although we did not assess transplanted cells for
genetic alterations our studies strongly support the long-term safety and suggest a minimal risk
of malignant transformation of ENCC transplants or metastatic spread.
In conclusion, our findings demonstrate that within the context of in vivo transplantation
postnatal ENCCs are able to engraft successfully and safely within recipient mouse bowel.
These observations significantly support and advance the development of cell replacement
strategies for a range of enteric neuropathies but this needs to be verified by further studies
detailing in vivo transplantations into more robust models of these devastating disorders.
Supporting Information
S1 Fig. Spread of YFP+ mouse ENCC following transplantation into in vivo gut. A. YFP
+ transplanted cells migrate from the presumptive site of transplantation (asterisk) to form
branching networks. Arrowheads indicate oral- and anal-most cells. B.Quantification of the
area covered by networks of transplanted cells originating from an individual neurosphere
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plotted over time (days post-transplant), (R = 0.54; n = 28; p<0.01). C. Quantification of the
maximal migration of transplanted YFP+ cells from the presumptive site of transplantation
plotted as a function of time (days post-transplant) (R = 0.68; n = 32; p<0.01).D.Quantifica-
tion of the maximal proximal-distal spread of transplanted YFP+ cells plotted as a function of
time (days post-transplant) (R = 0.51; n = 28; p<0.01). Scale bar in A = 250μm.
(TIF)
S2 Fig. Transplanted YFP+ ENCC generate neurons and glia, including different neuronal
subtypes. A-G. 3D reconstructions (low and high magnification) of z-stacks taken from whole-
mount gut preparations in which YFP+ transplanted cells (green) are immunohistochemically
labelled with a range of ENS markers (red; co-expression yellow and arrowheads). Trans-
planted cells express the pan neuronal marker TuJ1 (A), inhibitory neuronal markers nNOS
and VIP (B, E), excitatory neuronal markers ChAT and Calbindin (C, D), and the glial markers
S100 and GFAP (F, G). DAPI labels nuclei in blue. Scale bar in A-G low magnification = 50μm;
high magnification = 10μm. Insets show individual channels.
(TIF)
S3 Fig. Proliferation and safety data for transplanted YFP+ mouse ENCC. A. Percentage of
TuJ1+, nNOS+ and S100+ cells in the total population of transplanted cells (n = 13, 3, 3 respec-
tively). B. Percentage of TuJ1+, nNOS+ and S100+ transplanted cells showing BrdU incorpo-
ration (n = 13, 3, 3 respectively). C. Percentage of TuJ1+ transplanted cells showing BrdU
incorporation with high inter-sample variability, but low within-sample variability.
(TIF)
S1 Movie. Ca2+ responses of transplanted YFP+ mouse neurons following electrical stimu-
lation of endogenous ENS. Representative videos of Ca2+ responses following point stimula-
tion of the endogenous ENS. Left panel shows activation of transplanted YFP+ cells in control
conditions. In the presence of 1μMTTX, evoked Ca2+ responses are abolished (middle panel)
and are restored after washout (right panel). Equivalent transplanted cells (Fig 2B), Ca2+




Conceived and designed the experiments: NT JC CM DN AJB JMD. Performed the experi-
ments: JC CM DNWB SC. Analyzed the data: JC CM NT. Contributed reagents/materials/
analysis tools: JC CM DN NT AJB PVBWB. Wrote the paper: JC NT DN CM AJB JMD.
References
1. Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, et al. Hirschsprung
disease, associated syndromes and genetics: a review. J Med Genet. 2008; 45(1):1–14. Epub 2007/
10/30. doi: 10.1136/jmg.2007.053959 PMID: 17965226.
2. Chuenkova MV, Pereiraperrin M. Neurodegeneration and neuroregeneration in Chagas disease. Adv
Parasitol. 2011; 76:195–233. Epub 2011/09/03. doi: 10.1016/B978-0-12-385895-5.00009–8 PMID:
21884893.
3. McKeown SJ, Stamp L, Hao MM, Young HM. Hirschsprung disease: a developmental disorder of the
enteric nervous system.Wiley Interdiscip Rev Dev Biol. 2013; 2(1):113–29. Epub 2013/06/27. doi: 10.
1002/wdev.57 PMID: 23799632.
4. Facer P, Knowles CH, Thomas PK, Tam PK, Williams NS, Anand P. Decreased tyrosine kinase C
expression may reflect developmental abnormalities in Hirschsprung's disease and idiopathic slow-
transit constipation. Br J Surg. 2001; 88(4):545–52. Epub 2001/04/12. doi: 10.1046/j.1365-2168.2001.
01731.x PMID: 11298623.
In Vivo Transplantation of Enteric Neural Crest Cells
PLOS ONE | DOI:10.1371/journal.pone.0147989 January 29, 2016 14 / 17
5. Geramizadeh B, Hayati K, Rahsaz M, Hosseini SV. Assessing the interstitial cells of Cajal, cells of
enteric nervous system and neurotransmitters in slow transit constipation, using immunohistochemistry
for CD117, PGP9.5 and serotonin. Hepatogastroenterology. 2009; 56(96):1670–4. Epub 2010/03/11.
PMID: 20214215.
6. Giorgio V, Borrelli O, Smith VV, Rampling D, Koglmeier J, Shah N, et al. High-resolution colonic
manometry accurately predicts colonic neuromuscular pathological phenotype in pediatric slow transit
constipation. Neurogastroenterol Motil. 2013; 25(1):70–8 e8-9. Epub 2012/10/04. doi: 10.1111/nmo.
12016 PMID: 23030503.
7. Wedel T, Spiegler J, Soellner S, Roblick UJ, Schiedeck TH, Bruch HP, et al. Enteric nerves and intersti-
tial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology.
2002; 123(5):1459–67. Epub 2002/10/31. PMID: 12404220.
8. Burns AJ, Thapar N. Neural stem cell therapies for enteric nervous system disorders. Nat Rev Gastro-
enterol Hepatol. 2014; 11(5):317–28. Epub 2013/12/11. doi: 10.1038/nrgastro.2013.226 PMID:
24322895.
9. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neuro-
gastroenterol Motil. 2004; 16(5):515–31. Epub 2004/10/27. doi: 10.1111/j.1365-2982.2004.00538.x
PMID: 15500508.
10. Hotta R, Anderson RB, Kobayashi K, Newgreen DF, Young HM. Effects of tissue age, presence of neu-
rones and endothelin-3 on the ability of enteric neurone precursors to colonize recipient gut: implica-
tions for cell-based therapies. Neurogastroenterol Motil. 2010; 22(3):331–e86. Epub 2009/09/25. doi:
10.1111/j.1365-2982.2009.01411.x PMID: 19775251.
11. Hotta R, Natarajan D, Burns AJ, Thapar N. Stem cells for GI motility disorders. Curr Opin Pharmacol.
2011; 11(6):617–23. Epub 2011/11/08. doi: 10.1016/j.coph.2011.09.004 PMID: 22056114.
12. Hotta R, Thapar N. Advances in enteric neurobiology: how close are we to clinical use? J Pediatr Gas-
troenterol Nutr. 2011; 53 Suppl 2:S43–5. Epub 2012/01/12. PMID: 22235473.
13. Wagner JP, Sullins VF, Dunn JC. Skin-derived precursors generate enteric-type neurons in aganglionic
jejunum. J Pediatr Surg. 2014; 49(12):1809–14. Epub 2014/12/10. doi: 10.1016/j.jpedsurg.2014.09.
023 PMID: 25487489; PubMed Central PMCID: PMC4261145.
14. Wagner JP, Sullins VF, Dunn JC. Transplanted skin-derived precursor stem cells generate enteric gan-
glion-like structures in vivo. J Pediatr Surg. 2014; 49(8):1319–24; discussion 24–5. Epub 2014/08/06.
doi: 10.1016/j.jpedsurg.2014.01.061 PMID: 25092099; PubMed Central PMCID: PMC4122864.
15. Kwok CK, Tam PK, Ngan ES. Potential use of skin-derived precursors (SKPs) in establishing a cell-
based treatment model for Hirschsprung's disease. J Pediatr Surg. 2013; 48(3):619–28. Epub 2013/03/
14. doi: 10.1016/j.jpedsurg.2012.08.026 PMID: 23480922.
16. Findlay Q, Yap KK, Bergner AJ, Young HM, Stamp LA. Enteric neural progenitors are more efficient
than brain-derived progenitors at generating neurons in the colon. Am J Physiol Gastrointest Liver Phy-
siol. 2014; 307(7):G741–8. Epub 2014/08/16. doi: 10.1152/ajpgi.00225.2014 PMID: 25125684.
17. Le Douarin N, Kalcheim C. The Neural Crest. 2nd ed. Cambridge, United Kingdom: Cambridge Uni-
versity Press; 1999. 445 p.
18. Burns AJ, Thapar N. Advances in ontogeny of the enteric nervous system. Neurogastroenterol Motil.
2006; 18(10):876–87. Epub 2006/09/12. doi: 10.1111/j.1365-2982.2006.00806.x PMID: 16961690.
19. Furness JB. Novel gut afferents: Intrinsic afferent neurons and intestinofugal neurons. Auton Neurosci.
2006; 125(1–2):81–5. Epub 2006/02/16. doi: 10.1016/j.autneu.2006.01.007 PMID: 16476573.
20. Burns AJ. Migration of neural crest-derived enteric nervous system precursor cells to and within the
gastrointestinal tract. Int J Dev Biol. 2005; 49(2–3):143–50. Epub 2005/05/21. doi: 10.1387/ijdb.
041935ab PMID: 15906227.
21. Kapur RP, Yost C, Palmiter RD. A transgenic model for studying development of the enteric nervous
system in normal and aganglionic mice. Development. 1992; 116(1):167–75. Epub 1992/09/01. PMID:
1483385.
22. Sasselli V, Pachnis V, Burns AJ. The enteric nervous system. Dev Biol. 2012; 366(1):64–73. doi: 10.
1016/j.ydbio.2012.01.012 PMID: 22290331.
23. Bondurand N, Natarajan D, Thapar N, Atkins C, Pachnis V. Neuron and glia generating progenitors of
the mammalian enteric nervous system isolated from foetal and postnatal gut cultures. Development.
2003; 130(25):6387–400. Epub 2003/11/19. doi: 10.1242/dev.00857 PMID: 14623827.
24. Metzger M, Caldwell C, Barlow AJ, Burns AJ, Thapar N. Enteric nervous system stem cells derived
from human gut mucosa for the treatment of aganglionic gut disorders. Gastroenterology. 2009; 136
(7):2214–25 e1-3. Epub 2009/06/10. doi: 10.1053/j.gastro.2009.02.048 PMID: 19505425.
In Vivo Transplantation of Enteric Neural Crest Cells
PLOS ONE | DOI:10.1371/journal.pone.0147989 January 29, 2016 15 / 17
25. Almond S, Lindley RM, Kenny SE, Connell MG, Edgar DH. Characterisation and transplantation of
enteric nervous system progenitor cells. Gut. 2007; 56(4):489–96. Epub 2006/09/16. doi: 10.1136/gut.
2006.094565 PMID: 16973717; PubMed Central PMCID: PMC1856871.
26. Belkind-Gerson J, Carreon-Rodriguez A, Benedict LA, Steiger C, Pieretti A, Nagy N, et al. Nestin-
expressing cells in the gut give rise to enteric neurons and glial cells. Neurogastroenterol Motil. 2013;
25(1):61–9 e7. Epub 2012/09/25. doi: 10.1111/nmo.12015 PMID: 22998406; PubMed Central PMCID:
PMC3531577.
27. Hagl C, Schafer KH, Hellwig I, Barrenschee M, Harde J, Holtmann M, et al. Expression and function of
the Transforming Growth Factor-b system in the human and rat enteric nervous system. Neurogas-
troenterol Motil. 2013; 25(7):601–e464. Epub 2013/03/29. doi: 10.1111/nmo.12119 PMID: 23534441.
28. Lindley RM, Hawcutt DB, Connell MG, Almond SL, Vannucchi MG, Faussone-Pellegrini MS, et al.
Human and mouse enteric nervous system neurosphere transplants regulate the function of aganglio-
nic embryonic distal colon. Gastroenterology. 2008; 135(1):205–16 e6. Epub 2008/06/03. doi: 10.1053/
j.gastro.2008.03.035 PMID: 18515088.
29. Lindley RM, Hawcutt DB, Connell MG, Edgar DH, Kenny SE. Properties of secondary and tertiary
human enteric nervous system neurospheres. J Pediatr Surg. 2009; 44(6):1249–55; discussion 55–6.
Epub 2009/06/16. doi: 10.1016/j.jpedsurg.2009.02.048 PMID: 19524749.
30. Metzger M, Bareiss PM, Danker T, Wagner S, Hennenlotter J, Guenther E, et al. Expansion and differ-
entiation of neural progenitors derived from the human adult enteric nervous system. Gastroenterology.
2009; 137(6):2063–73 e4. Epub 2009/06/25. doi: 10.1053/j.gastro.2009.06.038 PMID: 19549531.
31. Rauch U, Hansgen A, Hagl C, Holland-Cunz S, Schafer KH. Isolation and cultivation of neuronal pre-
cursor cells from the developing human enteric nervous system as a tool for cell therapy in dysganglio-
nosis. Int J Colorectal Dis. 2006; 21(6):554–9. Epub 2005/11/04. doi: 10.1007/s00384-005-0051-z
PMID: 16267668.
32. Binder E, Natarajan D, Cooper J, Kronfli R, Cananzi M, Delalande JM, et al. Enteric neurospheres are
not specific to neural crest cultures: implications for neural stem cell therapies. PLoS One. 2015; 10(3):
e0119467. doi: 10.1371/journal.pone.0119467 PMID: 25799576.
33. Dettmann HM, Zhang Y, Wronna N, Kraushaar U, Guenther E, Mohr R, et al. Isolation, expansion and
transplantation of postnatal murine progenitor cells of the enteric nervous system. PLoS One. 2014; 9
(5):e97792. Epub 2014/05/30. doi: 10.1371/journal.pone.0097792 PMID: 24871092; PubMed Central
PMCID: PMC4037209.
34. Hetz S, Acikgoez A, Voss U, Nieber K, Holland H, Hegewald C, et al. In vivo transplantation of neuro-
sphere-like bodies derived from the human postnatal and adult enteric nervous system: a pilot study.
PLoS One. 2014; 9(4):e93605. Epub 2014/04/05. doi: 10.1371/journal.pone.0093605 PMID:
24699866; PubMed Central PMCID: PMC3974735.
35. Hotta R, Stamp LA, Foong JP, McConnell SN, Bergner AJ, Anderson RB, et al. Transplanted progeni-
tors generate functional enteric neurons in the postnatal colon. J Clin Invest. 2013; 123(3):1182–91.
Epub 2013/03/05. doi: 10.1172/JCI65963 PMID: 23454768; PubMed Central PMCID: PMC3582137.
36. Nishikawa R, Hotta R, Shimojima N, Shibata S, Nagoshi N, Nakamura M, et al. Migration and differenti-
ation of transplanted enteric neural crest-derived cells in murine model of Hirschsprung's disease. Cyto-
technology. 2014. Epub 2014/09/19. doi: 10.1007/s10616-014-9754-8 PMID: 25230796.
37. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. Modification of gene activity in
mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol. 1998; 8
(24):1323–6. Epub 1998/12/09. PMID: 9843687.
38. Druckenbrod NR, Epstein ML. The pattern of neural crest advance in the cecum and colon. Dev Biol.
2005; 287(1):125–33. Epub 2005/10/04. doi: 10.1016/j.ydbio.2005.08.040 PMID: 16197939.
39. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, et al. Cre reporter strains produced
by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001; 1:4. Epub 2001/
04/12. PMID: 11299042; PubMed Central PMCID: PMC31338.
40. Bondurand N, Natarajan D, Barlow A, Thapar N, Pachnis V. Maintenance of mammalian enteric ner-
vous system progenitors by SOX10 and endothelin 3 signalling. Development. 2006; 133(10):2075–86.
doi: 10.1242/dev.02375 PMID: 16624853.
41. Schneider CA, RasbandWS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature
methods. 2012; 9(7):671–5. Epub 2012/08/30. PMID: 22930834.
42. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source
platform for biological-image analysis. Nature methods. 2012; 9(7):676–82. doi: 10.1038/nmeth.2019
PMID: 22743772; PubMed Central PMCID: PMC3855844.
43. Thevenaz P, Ruttimann UE, Unser M. A pyramid approach to subpixel registration based on intensity.
IEEE transactions on image processing: a publication of the IEEE Signal Processing Society. 1998; 7
(1):27–41. doi: 10.1109/83.650848 PMID: 18267377.
In Vivo Transplantation of Enteric Neural Crest Cells
PLOS ONE | DOI:10.1371/journal.pone.0147989 January 29, 2016 16 / 17
44. Hao MM, BoesmansW, Van den Abbeel V, Jennings EA, Bornstein JC, Young HM, et al. Early emer-
gence of neural activity in the developing mouse enteric nervous system. The Journal of neuroscience:
the official journal of the Society for Neuroscience. 2011; 31(43):15352–61. Epub 2011/10/28. doi: 10.
1523/JNEUROSCI.3053-11.2011 PMID: 22031881.
45. BoesmansW, Martens MA, Weltens N, Hao MM, Tack J, Cirillo C, et al. Imaging neuron-glia interac-
tions in the enteric nervous system. Frontiers in cellular neuroscience. 2013; 7:183. Epub 2013/10/25.
doi: 10.3389/fncel.2013.00183 PMID: 24155689; PubMed Central PMCID: PMC3801083.
46. Goto K, Kawahara I, Inada H, Misawa H, Kuniyasu H, Nabekura J, et al. Activation of 5-HT receptors
facilitates neurogenesis from transplanted neural stem cells in the anastomotic ileum. J Physiol Sci.
2015. Epub 2015/09/04. doi: 10.1007/s12576-015-0396-1 PMID: 26335766.
47. Laranjeira C, Sandgren K, Kessaris N, RichardsonW, Potocnik A, Vanden Berghe P, et al. Glial cells in
the mouse enteric nervous system can undergo neurogenesis in response to injury. J Clin Invest. 2011;
121(9):3412–24. Epub 2011/08/26. doi: 10.1172/JCI58200 PMID: 21865647; PubMed Central PMCID:
PMC3163972.
48. Ghoshal UC, Daschakraborty SB, Singh R. Pathogenesis of achalasia cardia. World journal of gastro-
enterology: WJG. 2012; 18(24):3050–7. doi: 10.3748/wjg.v18.i24.3050 PMID: 22791940; PubMed
Central PMCID: PMC3386318.
49. Takahashi T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal
tract. J Gastroenterol. 2003; 38(5):421–30. doi: 10.1007/s00535-003-1094-y PMID: 12768383.
50. Stamp LA, Obermayr F, Pontell L, Young HM, Xie D, Croaker DH, et al. Surgical Intervention to Rescue
Hirschsprung Disease in a Rat Model. J Neurogastroenterol Motil. 2015; 21(4):552–9. Epub 2015/10/
02. doi: 10.5056/jnm15079 PMID: 26424040.
51. Dickson EJ, Heredia DJ, McCann CJ, Hennig GW, Smith TK. The mechanisms underlying the genera-
tion of the colonic migrating motor complex in both wild-type and nNOS knockout mice. Am J Physiol
Gastrointest Liver Physiol. 2010; 298(2):G222–32. Epub 2009/12/05. doi: 10.1152/ajpgi.00399.2009
PMID: 19959818; PubMed Central PMCID: PMC2822500.
52. Fox DA, Epstein ML, Bass P. Surfactants selectively ablate enteric neurons of the rat jejunum. J Phar-
macol Exp Ther. 1983; 227(2):538–44. Epub 1983/11/01. PMID: 6195330.
In Vivo Transplantation of Enteric Neural Crest Cells
PLOS ONE | DOI:10.1371/journal.pone.0147989 January 29, 2016 17 / 17
